PolymarketVérifier la disponibilitéSans KYC2% de fraisDonnées de résolution vérifiéesBien calibréProbabilité implicite actuelle
Non 94.1%
Qualité du marché
67 / 100
Qualité moyenneVolume 24h
8,1 €
Liquidité
32,8 k €
Liquidité élevéeAchat / Vente
5.0% / 6.0%
Écart
1.0 pt
Spread serréCommentaires
7
Données du marché
Mis à jour il y a 2 minutes
4 mai 26, 14:41 UTC1 janv. 27, 04:59 UTC
Tendances
Marchés Associés
Questions liées pour le contexte, et non une comparaison de contrats équivalents.
Will a Hantavirus Vaccine be created in 2026? [Polymarket]
Manifold MarketsHantavirus pandemic in 2026?
PolymarketWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
KalshiHantavirus pandemic in 2026? [Polymarket]
Manifold MarketsWhat will happen related to the Hantavirus in 2026?
Manifold MarketsWill CDC cut the childhood vaccine schedule below 11 diseases in 2026?
KalshiRègles
This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.
- Otherwise, this market will resolve to "No".
- The primary resolution source for this market will be official information from the FDA, including its list of approved vaccines (https://www.fda.gov/vaccines-blood-biologics/vaccines/vaccines-licensed-use-united-states), however a consensus of credible reporting may also be used.
Marchés ouverts
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No97%
- Yes3%
- Volume total
- 15,6 M €
- Volume 24h
- 20,4 k €
POLYMARKETNew pandemic in 2026?
- No94.1%
- Yes5.9%
- Volume total
- 919 k €
- Volume 24h
- 4,2 k €
KALSHIMedtronic cardiovascular growth in Q2
- Above 8%92%
- Above 9%81%
- Above 11.5%53%
+6 résultats de plus
- Volume total
- 2,6 k €
- Volume 24h
- 2,6 k €
POLYMARKETMeasles cases in U.S. in 2026?
- ↑3.5k+0.1pt100%
- ↑500+0.1pt100%
- ↑1k+0.1pt100%
+9 résultats de plus
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000+3.0pt61%
+2 résultats de plus
- Volume total
- 866,7 k €
- Volume 24h
- 1,7 k €
KALSHIPandemic in 2026?
- No95%
- Yes5%
- Volume total
- 611,8 k €
- Volume 24h
- 1,1 k €
- When will Beam Therapeutics submit a BLA for Risto-cel?
- Which countries will report an Ebola disease case before October?
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
- Heidi Overton confirmed as FDA Commissioner by which date?
- Will the FDA approve retatrutide?
- Ebola pandemic in 2026?
- Will WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- Measles cases in U.S. by September 30?
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- FDA approves Retatrutide this year?
Questions fréquentes
- Quelles sont les probabilités actuelles pour Hantavirus vaccine in 2026? ?
- Polymarket cote No à 94% au 10 septembre 2026.
- Quand Hantavirus vaccine in 2026? sera-t-il résolu ?
- Hantavirus vaccine in 2026? doit être résolu le 1 janvier 2027.
- Comment Hantavirus vaccine in 2026? est-il réglé ?
- Polymarket règle ce marché comme suit : This market will resolve to "Yes" if any vaccine intended for humans and inoculating against Hantavirus (including Hantavirus Pulmonary Syndrome (HPS) or Hemorrhagic Fever with Renal Syndrome (HFRS)) receives full approval from the U.S. Food and Drug Administration between market creation and December 31, 2026, 11:59 PM ET.